Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Background: Prenatal exposure to perfluoroalkyl substances (PFAS) has been previously associated with preeclampsia, although findings are mixed with respect to the direction and magnitude of effect. To our knowledge, no studies have examined associations between PFAS and preeclampsia subtypes, which may have distinct etiologies. Objective: We examined associations between PFAS, any preeclampsia diagnosis, and early- and late-onset preeclampsia. In addition, we estimated associations between PFAS and the angiogenic biomarkers soluble fms-like tyrosine kinase-1 (sFLT-1) and placental growth factor (PlGF), which provide an estimate of pro- and anti-angiogenic activity within the placenta. Methods: This case–control study (n=75 cases, n=75 controls) was sampled from the LIFECODES birth cohort. Nine legacy PFAS were quantified in maternal plasma from early pregnancy (median= 10 wk) and angiogenic biomarkers were quantified in maternal plasma from four study visits (median= 10, 18, 26, and 35 wk). Logistic regression was used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) of the association between an interquartile range (IQR)-increase in PFAS and preeclampsia outcomes. Linear regression was used to estimate associations between an IQR-increase in PFAS and concentrations of angiogenic biomarkers. Results: Both perfluorodecanoic acid (OR= 1.64, 95% CI: 1.08, 2.47) and perfluorooctanesulfonic acid (OR= 1.60, 95% CI: 1.06, 2.43) were associated with higher odds of late-onset preeclampsia. Associations tended to be below the null for early-onset preeclampsia, although findings were imprecise. Few associations were noted between PFAS and angiogenic biomarkers. Discussion: Maternal PFAS concentrations were associated with higher odds of late-onset preeclampsia. Heterogeneity of preeclampsia should be considered in future studies because populations may have different distributions of disease subtypes. https://doi.org/10.1289/EHP9091
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101 · cited 1×
“These factors are released by the placenta into the maternal circulation, giving an indication of the balance of anti-angiogenic (i.e., sFLT-1) to pro-angiogenic (i.e., PlGF) activity within the placenta (Maynard et al. 2003; McElrath et al. 2012).”
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Estimation of Average Concentration in the Presence of Nondetectable Values
Hornung, R. W., & Reed, L. D. (1990) · Applied Occupational and Environmental Hygiene · doi:10.1080/1047322x.1990.10389587 · Cited by 3,495
Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60279-6 · Cited by 2,850
Sunderland, E. M., Hu, X. C., Dassuncao, C., Tokranov, A. K., Wagner, C. C., & Allen, J. G. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0094-1 · Cited by 2,786
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552
Onuegbu, A. J., Olisekodiaka, J. M., Udo, J. U., Umeononihu, O., Amah, U. K., Okwara, J. E., & Atuegbu, C. (2015) · Medical Principles and Practice · doi:10.1159/000381778 · Cited by 2,044
The Uterine Spiral Arteries In Human Pregnancy: Facts and Controversies
Pijnenborg, R., Vercruysse, L., & Hanssens, M. (2006) · Placenta · doi:10.1016/j.placenta.2005.12.006 · Cited by 1,205
Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis
Ananth, C. V., Keyes, K. M., & Wapner, R. J. (2013) · BMJ · doi:10.1136/bmj.f6564 · Cited by 940 · cited 1×
“Preeclampsia is a reproductive disorder that a ff ects ∼ 2 – 8 % of all pregnancies within the United States (Ananth et al. 2013) and represents a major contributor to maternal mortality (Steegers et al. 2010).”
Zhou, Y., Damsky, C. H., & Fisher, S. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119388 · Cited by 927
Lisonkova, S., & Joseph, K. S. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.08.019 · Cited by 924
The Two Stage Model of Preeclampsia: Variations on the Theme
Roberts, J. M., & Hubel, C. A. (2009) · Placenta · doi:10.1016/j.placenta.2008.11.009 · Cited by 922
Subclassification of Preeclampsia
von Dadelszen, P., Magee, L. A., & Roberts, J. M. (2003) · Hypertension in Pregnancy · doi:10.1081/prg-120021060 · Cited by 763
Committee Opinion No. 700: Methods for estimating the due date
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002046 · Cited by 683
The two-stage placental model of preeclampsia: An update
Staff, A. C. (2019) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2019.07.004 · Cited by 598
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003892 · Cited by 577
A Critical Review of Early-Onset and Late-Onset Preeclampsia
Raymond, D., & Peterson, E. (2011) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3182331028 · Cited by 551
Biomonitoring of Perfluoroalkyl Acids in Human Urine and Estimates of Biological Half-Life
Zhang, Y., Beesoon, S., Zhu, L., & Martin, J. W. (2013) · Environmental Science & Technology · doi:10.1021/es401905e · Cited by 530 · cited 1×
“Because the half-lives of some of these chemicals are long, ranging from several days to over a decade (ATSDR 2021), and they do not degrade in the environment (Sunderland et al. 2019; Zhang et al. 2013), they are sometimes referred to as forever chemicals.”
Blake, B. E., & Fenton, S. E. (2020) · Toxicology · doi:10.1016/j.tox.2020.152565 · Cited by 499 · cited 1×
“Exposure to PFAS has been linked to a wide array of adverse health outcomes, including reproductive outcomes (Blake and Fenton 2020).”
Mongraw-Chaffin, M. L., Cirillo, P. M., & Cohn, B. A. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.150078 · Cited by 434
Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity
Redman, C. W. G., & Staff, A. C. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.003 · Cited by 361
Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness
Roberts, J. M., Rich-Edwards, J. W., McElrath, T. F., Garmire, L., Myatt, L., & for the Global Pregnancy Collaboration (2021) · Hypertension · doi:10.1161/hypertensionaha.120.14781 · Cited by 311 · cited 2×
“…Health Perspectives 107004-5 129(10) October 2021 preeclampsia subtypes, which are believed to have distinct etiologies (Raymond and Peterson 2011; Roberts et al. 2021; von Dadelszen et al. 2003) and may therefore have di ff erent associations with environmental exposures, such as PFAS.”
Self-citationAlbumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma
Forsthuber, M., Kaiser, A. M., Granitzer, S., Hassl, I., Hengstschläger, M., Stangl, H., & Gundacker, C. (2020) · Environment International · doi:10.1016/j.envint.2019.105324 · Cited by 272
Serum Levels of Perfluorooctanoic Acid and Perfluorooctane Sulfonate and Pregnancy Outcome
Stein, C. R., Savitz, D. A., & Dougan, M. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp212 · Cited by 262
Blake, B. E., Cope, H. A., Hall, S. M., Keys, R. D., Mahler, B. W., McCord, J., Scott, B., Stapleton, H. M., Strynar, M. J., Elmore, S. A., et al. (2020) · Environmental Health Perspectives · doi:10.1289/ehp6233 · Cited by 261
Calafat, A. M., Kato, K., Hubbard, K., Jia, T., Botelho, J. C., & Wong, L.-Y. (2019) · Environment International · doi:10.1016/j.envint.2019.105048 · Cited by 242
Blake, B. E., Pinney, S. M., Hines, E. P., Fenton, S. E., & Ferguson, K. K. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.07.042 · Cited by 236 · cited 1×
“Environmental Health Perspectives 107004-7 129(10) October 2021 of PFAS is sensitive to changes in kidney function (Blake et al. 2018; Jain and 2019; Sagiv et al. 2015), especially albumin excretion given that albumin is the primary carrier protein of PFAS in the blood (Forsthuber et al. 2020).”
Self-citationGöckener, B., Weber, T., Rüdel, H., Bücking, M., & Kolossa-Gehring, M. (2020) · Environment International · doi:10.1016/j.envint.2020.106123 · Cited by 224 · cited 2×
“As a result, PFAS are ubiquitous in the environment and are commonly detected in humans, both in the United States (Calafat et al. 2019) and globally (Göckener et al. 2020; Seo et al. 2018; Timmermann et al. 2020).”
Kuklenyik, Z., Needham, L. L., & Calafat, A. M. (2005) · Analytical Chemistry · doi:10.1021/ac050671l · Cited by 203
The role of cellular senescence in ageing of the placenta
Cox, L. S., & Redman, C. (2017) · Placenta · doi:10.1016/j.placenta.2017.01.116 · Cited by 181
Sagiv, S. K., Rifas-Shiman, S. L., Webster, T. F., Mora, A. M., Harris, M. H., Calafat, A. M., Ye, X., Gillman, M. W., & Oken, E. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b02489 · Cited by 173
Perfluorooctanoic Acid Exposure and Pregnancy Outcome in a Highly Exposed Community
Savitz, D. A., Stein, C. R., Bartell, S. M., Elston, B., Gong, J., Shin, H.-M., & Wellenius, G. A. (2012) · Epidemiology · doi:10.1097/ede.0b013e31824cb93b · Cited by 171
Sagiv, S. K., Rifas-Shiman, S. L., Fleisch, A. F., Webster, T. F., Calafat, A. M., Ye, X., Gillman, M. W., & Oken, E. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwx332 · Cited by 167
McElrath, T. F., Lim, K.-H., Paré, E., Rich-Edwards, J. W., Pucci, D., Troisi, R. J., & Parry, S. I. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.010 · Cited by 165
Self-citationSeo, S.-H., Son, M.-H., Choi, S.-D., Lee, D.-H., & Chang, Y.-S. (2018) · Environment International · doi:10.1016/j.envint.2018.01.025 · Cited by 152
Huang, R., Chen, Q., Zhang, L., Luo, K., Chen, L., Zhao, S., Feng, L., & Zhang, J. (2019) · Environmental Health · doi:10.1186/s12940-018-0445-3 · Cited by 140
Meng, Q., Inoue, K., Ritz, B., Olsen, J., & Liew, Z. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15091832 · Cited by 138
Agrawal, S., Shinar, S., Cerdeira, A. S., Redman, C., & Vatish, M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13360 · Cited by 123
Are Early and Late Preeclampsia Distinct Subclasses of the Disease—What Does the Placenta Reveal?
van der Merwe, J. L., Hall, D. R., Wright, C., Schubert, P., & Grové, D. (2010) · Hypertension in Pregnancy · doi:10.3109/10641950903572282 · Cited by 102
Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis
Allen, R. E., Rogozińska, E., Cleverly, K., Aquilina, J. T., & Thangaratinam, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.09.027 · Cited by 95
Timmermann, C. A. G., Jensen, K. J., Nielsen, F., Budtz-Jørgensen, E., van der Klis, F., Benn, C. S., Grandjean, P., & Fisker, A. B. (2020) · Environmental Health Perspectives · doi:10.1289/ehp6517 · Cited by 94
Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women
Wikström, S., Lindh, C. H., Shu, H., & Bornehag, C.-G. (2019) · Scientific Reports · doi:10.1038/s41598-019-45483-7 · Cited by 93
Microalbuminuria, Preeclampsia, and Preterm Delivery in Pregnant Women With Type 1 Diabetes
Jensen, D. M., Damm, P., Ovesen, P., Mølsted-Pedersen, L., Beck-Nielsen, H., Westergaard, J. G., Moeller, M., & Mathiesen, E. R. (2010) · Diabetes Care · doi:10.2337/dc09-1219 · Cited by 88
Jain, R. B., & Ducatman, A. (2019) · Environmental Research · doi:10.1016/j.envres.2019.04.034 · Cited by 88
Szilagyi, J. T., Freedman, A. N., Kepper, S. L., Keshava, A. M., Bangma, J. T., & Fry, R. C. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa043 · Cited by 84
Borghese, M. M., Walker, M., Helewa, M. E., Fraser, W. D., & Arbuckle, T. E. (2020) · Environment International · doi:10.1016/j.envint.2020.105789 · Cited by 79
Starling, A. P., Engel, S. M., Richardson, D. B., Baird, D. D., Haug, L. S., Stuebe, A. M., Klungsoyr, K., Harmon, Q., Becher, G., Thomsen, C., et al. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwt432 · Cited by 77
Population-based trends and risk factors of early- and late-onset preeclampsia in Taiwan 2001–2014
You, S.-H., Cheng, P., Chung, T., Kuo, C., Wu, H., & Chu, P. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1845-7 · Cited by 70
Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight Gain
Ashley-Martin, J., Dodds, L., Arbuckle, T., Morisset, A.-S., Fisher, M., Bouchard, M., Shapiro, G., Ettinger, A., Monnier, P., Dallaire, R., et al. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13010146 · Cited by 55
Pinheiro, C. C., Rayol, P., Gozzani, L., dos Reis, L. M., Zampieri, G., Dias, C. B., & Woronik, V. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4432 · Cited by 54
Waterfield, G., Rogers, M., Grandjean, P., Auffhammer, M., & Sunding, D. (2020) · Environmental Health · doi:10.1186/s12940-020-00591-0 · Cited by 54
Ekbom, P., Damm, P., Nørgaard, K., Clausen, P., Feldt‐Rasmussen, U., Feldt‐Rasmussen, B., Nielsen, L. H., Mølsted‐Pedersen, L., & Mathiesen, E. R. (2000) · Diabetologia · doi:10.1007/s001250051471 · Cited by 54
Rylander, L., Lindh, C. H., Hansson, S. R., Broberg, K., & Källén, K. (2020) · Toxics · doi:10.3390/toxics8020043 · Cited by 52
Huo, X., Huang, R., Gan, Y., Luo, K., Aimuzi, R., Nian, M., Ao, J., Feng, L., Tian, Y., Wang, W., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.105656 · Cited by 49
Baweja, S., Kent, A. B., Masterson, R., Roberts, S., & Mcmahon, L. (2011) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.02960.x · Cited by 47
Late Onset Preeclampsia is not an Innocuous Condition
Kenneth, L., Hall, D. R., Gebhardt, G., & Grove, D. (2010) · Hypertension in Pregnancy · doi:10.3109/10641950902777697 · Cited by 47
Pham, A., Zhang, J., & Feng, L. (2020) · Reproductive Toxicology · doi:10.1016/j.reprotox.2020.10.013 · Cited by 44
Jiang, W., Deng, Y., Song, Z., Xie, Y., Gong, L., Chen, Y., & Kuang, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00051 · Cited by 39
Mitro, S. D., Sagiv, S. K., Rifas‐Shiman, S. L., Calafat, A. M., Fleisch, A. F., Jaacks, L. M., Williams, P. L., Oken, E., & James-Todd, T. M. (2020) · Obesity · doi:10.1002/oby.22933 · Cited by 38
Singer, A. B., Whitworth, K. W., Haug, L. S., Sabaredzovic, A., Impinen, A., Papadopoulou, E., & Longnecker, M. P. (2018) · Environmental Research · doi:10.1016/j.envres.2018.05.019 · Cited by 35
Poteser, M., Hutter, H., Moshammer, H. M., & Weitensfelder, L. (2020) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2020.113566 · Cited by 33
Honigberg, M. C., Cantonwine, D. E., Thomas, A. M., Lim, K.-H., Parry, S. I., & McElrath, T. F. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.170 · Cited by 32
Self-citationAngiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis
Veisani, Y., Jenabi, E., Delpisheh, A., & Khazaei, S. (2019) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v17i1.3815 · Cited by 32
The Clinical Value of Microtransferrinuria and Microalbuminuria in the Prediction of Pre-eclampsia
Shaarawy, M., & Salem, M. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.008 · Cited by 27
Season of Conception, Smoking, and Preeclampsia in Norway
Weinberg, C. R., Shi, M., Basso, O., DeRoo, L. A., Harmon, Q. E., Wilcox, A. J., & Skjærven, R. (2017) · Environmental Health Perspectives · doi:10.1289/ehp963 · Cited by 22
Microalbuminuria - A better marker in hypertensive disorders of pregnancy
Manjrekar, P., Joseph, M., Babu, R. P., Christy, A. L., & Hegde, A. (2015) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.164574 · Cited by 6
Cited by
Public Health Risks of PFAS-Related Immunotoxicity Are Real
Bline, A. P., DeWitt, J. C., Kwiatkowski, C. F., Pelch, K. E., Reade, A., & Varshavsky, J. (2024) · Current Environmental Health Reports · doi:10.1007/s40572-024-00441-y · Cited by 149
Taibl, K. R., Schantz, S., Aung, M. T., Padula, A., Geiger, S., Smith, S., Park, J.-S., Milne, G. L., Robinson, J. F., Woodruff, T. J., et al. (2022) · Environment International · doi:10.1016/j.envint.2022.107541 · Cited by 113
Taibl, K. R., Dunlop, A. L., Barr, D. B., Li, Y., Eick, S. M., Kannan, K., Ryan, P. B., Schroder, M., Rushing, B. R., Fennell, T. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38710-3 · Cited by 122
Padula, A. M., Ning, X., Bakre, S., Barrett, E. S., Bastain, T., Bennett, D. H., Bloom, M. S., Breton, C. V., Dunlop, A. L., Eick, S. M., et al. (2023) · Environmental Health Perspectives · doi:10.1289/ehp10723 · Cited by 110
Self-citationPFAS Exposures and the Human Metabolome: A Systematic Review of Epidemiological Studies
India-Aldana, S., Yao, M., Midya, V., Colicino, E., Chatzi, L., Chu, J., Gennings, C., Jones, D. P., Loos, R. J. F., Setiawan, V. W., et al. (2023) · Current Pollution Reports · doi:10.1007/s40726-023-00269-4 · Cited by 114
Metadata
- Authors
- Bommarito, P. A., Ferguson, K. K., Meeker, J. D., McElrath, T. F., & Cantonwine, D. E.
- Affiliations
- National Institutes of Health (US)
- University of Michigan (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Cantonwine, David E.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-10
- Volume
- 129
- Issue
- 10
- Pages
- 107004-107004
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- PMC
- PMC8509361
- OpenAlex
- W3206454742
- Semantic Scholar
- 784af87465cf506d3c197e653379c74ac4c0dda1
- Cited by
- 70
- References
- 69
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 15 · 2023: 13 · 2022: 13
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- Locations
- Environmental Health Perspectives (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences (ZIAES103321, P30ES017885)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- perfluorinated compounds, preeclampsia, late-onset preeclampsia, early-onset preeclampsia, perfluorodecanoic acid, PFOS, angiogenic biomarkers, soluble fms-like tyrosine kinase-1, placental growth factor, maternal plasma, prenatal exposure, placental angiogenesis
- MeSH terms
- Placenta Growth Factor, Female, Fluorocarbons, Humans, Pre-Eclampsia, Pregnancy, Biomarkers, Case-Control Studies, Vascular Endothelial Growth Factor Receptor-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.